Skin News and Research

RSS

Novel therapy for chronic graft-versus-host disease (GVHD) using Rituximab

Dana-Farber researchers found that rituximab reduced the severity of chronic graft-versus-host disease (GVHD) in 70 percent of the study participants.

27 Mar 2006

ADHD drug not safe for kids

According to a panel of experts advising the U.S. Food and Drug Administration (FDA), the drug Provigil, although effective in treating attention deficit hyperactivity disorder (ADHD) in children and teenagers, is not safe enough to win approval.

26 Mar 2006

Benefit of fish oils under question

In a turn up for the books, experts are now saying that contrary to the widely held belief that the omega 3 fats found in oily fish help prevent heart disease, this has not been proven.

26 Mar 2006

Fish enzymes and gelatine may be the new treatment for psoriasis and eczema

A new skin cream has shown promising results in the treatment of psoriasis and eczema. The cream contains fish enzymes and gelatine and is under development by researchers at the Norwegian University of Science and Technology (NTNU) in Trondheim and the University of Bergen, Norway.

23 Mar 2006

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).

23 Mar 2006

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have identified a defect in the immune response of people with the skin condition atopic dermatitis that puts them at risk of developing serious complications following smallpox vaccination.

23 Mar 2006

Potential therapeutic targets against serious side effects of smallpox vaccine

Smallpox is considered a potential terrorist weapon, but millions of people in the United States are currently advised not to get a vaccine to the disease because they are susceptible to developing a severe adverse reaction.

23 Mar 2006

"Sick building syndrome" is a hallmark of job stress and lack of support rather than an unhealthy building

Sick building syndrome describes a cluster of symptoms affecting the eyes, head, nose and throat and skin, all of which have been associated with the physical properties of office buildings.

23 Mar 2006

Increase in Vitamin E tied to fewer in utero deaths

Manipulating the in utero environment may alter the onset of cancers that appear later in the lives of mammals, according to a new University of Toronto study published in the journal Carcinogenesis.

23 Mar 2006

Gene discovered that causes dry skin and leads to eczema and asthma

Experts, lead by the University of Dundee, have discovered the gene which causes genetic skin conditions affecting millions of people.

21 Mar 2006

Facial injections of polylactic acid may help improve loss of fat in the face associated with HIV infection

Facial injections of polylactic acid, a synthetic biodegradable polymer, may help improve the debilitating facial lipoatrophy (loss of fat in the face) associated with HIV infection and its treatment, according to an article in the March issue of Archives of Dermatology.

21 Mar 2006

New research suggests it may be possible to separate the anticancer properties of vitamin D

At the right dose, vitamin D is important for bone development and may help protect against the development of several cancers, particularly colorectal cancer.

21 Mar 2006

53 percent more minimally-invasive procedures since 2000

Rest and relaxation seem like impossible feats to most Americans trying to balance the demands of family and career. This balancing act could account for the continued growth in minimally-invasive cosmetic plastic surgery procedures with 8.4 million performed in 2005.

20 Mar 2006

Rutgers researchers discover obesity gene

Rutgers researchers have identified a gene - and the molecular function of its protein product - that provides an important clue to further understanding obesity and may point the way to new drugs to control fat metabolism.

20 Mar 2006

Human papillomavirus may be a risk factor in developing squamous cell carcinoma

The study, published in the March 15 issue of the Journal of the National Cancer Institute, used new technology to detect antibodies from a strain of HPV on skin cancer samples.

20 Mar 2006

Patterns of fMRI activity dissociate overlapping functional brain areas that respond to biological motion

A swaying tree and a moving person activate distinctive areas of the brain's visual cortex, since recognizing people is essential for social interaction. So, an important question in exploring the visual system is how the visual cortex manages such specific recognition of "biological motion."

19 Mar 2006

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

University of Michigan scientists have found a common genetic variation in an immune system gene that makes people much more likely to develop psoriasis - a disfiguring inflammatory skin disease.

19 Mar 2006

Minimally invasive removal of the thyroid gland can work for many thyroid patients

Many patients with diseased thyroids have two safe, effective treatment options that can dramatically reduce the size of their neck incisions and speed recovery, researchers say.

19 Mar 2006

Antibody may reduce or eliminate tumors

San Diego State University researcher Roger Sabbadini has brought scientists one step closer to finding a cure for cancer with the creation of an antibody that hinders the growth of tumors by preventing blood vessel formation.

17 Mar 2006

FDA grants Cerexa fast track designation

Cerexa has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for PPI-0903, a next-generation, broad-spectrum, cephalosporin antibiotic, for the treatment of complicated skin and skin structure infections (cSSSI) caused by methicillin-resistant Staphylococcus aureus (MRSA).

17 Mar 2006

Skin News and Research

Novel therapy for chronic graft-versus-host disease (GVHD) using Rituximab

ADHD drug not safe for kids

Benefit of fish oils under question

Fish enzymes and gelatine may be the new treatment for psoriasis and eczema

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Immune system protein LL-37 critical in controlling replication of vaccinia virus

Potential therapeutic targets against serious side effects of smallpox vaccine

"Sick building syndrome" is a hallmark of job stress and lack of support rather than an unhealthy building

Increase in Vitamin E tied to fewer in utero deaths

Gene discovered that causes dry skin and leads to eczema and asthma

Facial injections of polylactic acid may help improve loss of fat in the face associated with HIV infection

New research suggests it may be possible to separate the anticancer properties of vitamin D

53 percent more minimally-invasive procedures since 2000

Rutgers researchers discover obesity gene

Human papillomavirus may be a risk factor in developing squamous cell carcinoma

Patterns of fMRI activity dissociate overlapping functional brain areas that respond to biological motion

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

Minimally invasive removal of the thyroid gland can work for many thyroid patients

Antibody may reduce or eliminate tumors

FDA grants Cerexa fast track designation

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News